CVS Group’s (CVSG) “Buy” Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of CVS Group (LON:CVSGFree Report) in a report released on Monday morning, Marketbeat reports. Deutsche Bank Aktiengesellschaft currently has a GBX 1,700 target price on the stock.

A number of other research firms have also commented on CVSG. Jefferies Financial Group lowered shares of CVS Group to a “hold” rating and lowered their price target for the stock from GBX 1,420 to GBX 1,350 in a research report on Thursday, July 9th. Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a report on Thursday, July 23rd. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, CVS Group currently has an average rating of “Moderate Buy” and an average target price of GBX 1,710.

Check Out Our Latest Stock Analysis on CVS Group

CVS Group Stock Down 0.2%

CVSG opened at GBX 1,252.97 on Monday. The stock has a fifty day moving average of GBX 1,227.24 and a 200-day moving average of GBX 1,245.57. The company has a market capitalization of £867.05 million, a P/E ratio of 18.19, a P/E/G ratio of 1.77 and a beta of 1.06. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07.

CVS Group declared that its Board of Directors has authorized a stock buyback plan on Tuesday, May 26th that authorizes the company to repurchase 0 shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Insiders Place Their Bets

In related news, insider Scott Morrison bought 987 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was purchased at an average cost of GBX 1,270 per share, for a total transaction of £12,534.90. 1.43% of the stock is owned by corporate insiders.

About CVS Group

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Recommended Stories

Analyst Recommendations for CVS Group (LON:CVSG)

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.